# Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine

> **NCT05140603** · — · UNKNOWN · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 150 (estimated)

## Conditions studied

- Hiv

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05140603
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-10-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05140603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05140603, "Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05140603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*